Skip to content

Effect of Surgical Masks in Preventing Acute Respiratory Infections

Randomized Controlled Trial to Evaluate the Efficacy of Surgical Masks in Preventing Acute Respiratory Infections

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07739446
Enrollment
2000
Registered
2026-07-31
Start date
2026-07-01
Completion date
2027-03-01
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Infections (ARIs), COVID - 19, Influenza

Keywords

acute respiratory infections, influenza, COVID - 19, public health and social measures, surgical mask, medical mask

Brief summary

The goal of this clinical trial is to evaluate the efficacy of surgical masks in preventing acute respiratory tract infections. The main question it aims to answer is: \- Does wearing a mask prevent you from getting acute respiratory tract infections, including influenza and COVID-19 Researchers will compare a surgical mask to no intervention to see if wearing a mask works to prevent acute respiratory infection. Participants will: * Wear or not wear a surgical mask every day * Answer a questionnaire every 2 weeks on symptoms, testing status, and behaviors This trial does not assess if wearing a mask prevents transmission of pathogens when you are already sick. Also, the trial does not assess whether universal masking (where everyone wears masks) works.

Interventions

BEHAVIORALSurgical masks

Participants in this group are provided with masks and asked to wear them every day

Sponsors

Chiba University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Those who originally do not wear a mask during the influenza season * Those aged 20 years or older and under 50 years at the time of providing informed consent * If assigned to the mask group, those who can agree to wear a mask when going outdoors for 3 to 4 months during the influenza season (excluding times such as when eating) * In the case of the non-mask group, those who can agree, in principle, not to wear a mask for 3 to 4 months during the influenza season * Those who can agree to undergo testing for both influenza and COVID-19 on the day of onset or the following day if symptoms suggestive of influenza, COVID-19, or a common cold (such as fever or respiratory symptoms) develop, and to visit a medical institution at their own expense for medical fees * Those who usually go out 3 or more days a week * Those who have obtained the agreement of cohabiting family members regarding participation * Those who, after receiving a thorough explanation regarding participation in this study and with full understanding, have provided written informed consent based on their own free will

Exclusion criteria

* Those who originally wear a mask during the influenza season and intend to continue doing so in the future * Those who are engaged in healthcare, food manufacturing, etc., and wear a mask during regular work * Those who are pregnant * Those with underlying medical conditions such as chronic liver disease, cancer, or cardiovascular disease * Those who have previously experienced allergic symptoms when wearing commercially available non-woven masks * Those who are planning long-term overseas travel exceeding one week during the influenza season, including the New Year holidays‡ * Others who did not provide consent

Design outcomes

Primary

MeasureTime frameDescription
Laboratory-confirmed influenzaFrom start of influenza season to the end of data collection at 14 weeksLaboratory-confirmed influenza based on testing done at healthcare facilities

Secondary

MeasureTime frameDescription
Acute respiratory infectionFrom start of influenza season to the end of data collection at 14 weeksSyndromic outcome based on self-report
Laboratory-confirmed COVID-19From start of influenza season to the end of data collection at 14 weeksLaboratory-confirmed COVID-19 based on testing done at healthcare facilities
Laboratory-confirmed influenza or COVID-19From start of influenza season to the end of data collection at 14 weeksLaboratory-confirmed influenza or COVID-19 based on testing done at healthcare facilities

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 4, 2026